Sentence examples for cardiovascular cells from inspiring English sources

Recently, investigation has specifically focused on factors that activate either endogenous progenitor cells or preexisting cardiomyocytes, to regenerate cardiovascular cells and replace the damaged heart tissues.

Mechanical stresses and strains on cardiovascular cells in vitro have been recognised and can be measured by a culture force monitor.

At Stanford, his focus is to utilize single-cell RNA-sequencing technology to elucidate patient-specific mechanisms of various cardiovascular diseases, characterize embryonic heart development, and optimize differentiation of iPSCs to subtypes of cardiovascular cells.

When specific targeting of organs, such as carcinoma and endothelial cardiovascular cells, is needed, different behavior may be expected in immobilized NPs, due to complete or partial elimination of the Brownian motion.

Our research combines in vitro disease models using cardiovascular cells generated from induced pluripotent stem cells (iPSCs) with high throughput screening to define disease mechanisms, identify drug targets and develop drug leads.

We have created a 3D microenvironment through electrospinning to study the impact of geometry and different extracellular proteins on the development of cardiac progenitor cells (Flk-1+) from resident stem cells and their differentiation into functional cardiovascular cells.

These studies revealed that the tissue response to disease is characterized by a marked accumulation of cardiovascular cells associated with inflammation, neovascularization, matrix production, eventually fibrosis, and in some cases calcification.

Injection of stromal cell-derived factor 1 (SDF1) has been shown to attract bone marrow-derived progenitor cells (BMPCs) from the blood that have the potential to differentiate into cardiovascular cells, which support angiogenesis, enabling the improvement of myocardial function.

In this issue of Cell Stem Cell, Ye et al. (2014) employ a growth-factor-loaded fibrin patch and show improved cardiovascular cell survival after cell transplantation into a porcine model of ischemia reperfusion.

(2014) employ a growth-factor-loaded fibrin patch and show improved cardiovascular cell survival after cell transplantation into a porcine model of ischemia reperfusion.

The Cardiovascular Cell Therapy Research Network was developed and funded by the National Heart ,Lung, and Blood Institute to address important questions such as timing of cell delivery and to accelerate research in the use of cell-based therapies.